By Michele Maatouk
Date: Thursday 15 Jan 2026
(Sharecast News) - Boston Scientific said on Thursday that it has agreed to buy thrombectomy company Penumbra in a $14.5bn deal.
| Market movers | 26-Feb-2008 | Chicago Tribune |
| Abbott falls behind in stents race | 01-Sep-2007 | Chicago Tribune |
| Rumors of rate cut lift stocks | 17-Aug-2007 | LA Times |
| Stent studies buoy Abbott | 23-May-2007 | Chicago Tribune |
| Johnson & Johnson's heart stent fails trial, der... | 08-May-2007 | Intl Herald Tribune |
| Currency | US Dollars |
| Share Price | $ 90.03 |
| Change Today | $ -3.71 |
| % Change | -3.96 % |
| 52 Week High | $108.09 |
| 52 Week Low | $87.22 |
| Volume | 27,909,054 |
| Shares Issued | 1,474.56m |
| Market Cap | $132,754m |
| Beta | 0.02 |
| RiskGrade | 132 |
| Time | Volume / Share Price |
| 15:59 | 169 @ $90.00 |
| 15:59 | 100 @ $90.00 |
| 15:59 | 132 @ $89.99 |
| 15:59 | 101 @ $90.00 |
| 15:59 | 105 @ $90.00 |
You are here: research